[1]卓然然,付盼盼.IL-16基因多态性与GDM的关系及对妊娠结局的影响[J].国际内分泌代谢杂志,2022,42(02):118-123.[doi:10.3760/cma.j.cn121383-20210106-01014]
　Zhuo Ranran,Fu Panpan..Association between IL-16 gene polymorphism and susceptibility to GDM and its influence on pregnancy outcome[J].International Journal of Endocrinology and Metabolism,2022,42(02):118-123.[doi:10.3760/cma.j.cn121383-20210106-01014]
点击复制

IL-16基因多态性与GDM的关系及对妊娠结局的影响()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
42
期数:
2022年02期
页码:
118-123
栏目:
论著
出版日期:
2022-03-20

文章信息/Info

Title:
Association between IL-16 gene polymorphism and susceptibility to GDM and its influence on pregnancy outcome
作者:
卓然然1; 付盼盼2
1海南省妇女儿童医学中心妇产科,海口 571100; 2陕西省延安市宝塔区人民医院妇产科 716000
Author(s):
Zhuo Ranran1;  Fu Panpan2.
1Department of Obstetrics and Gynecology, Hainan Women and Children Medical Center, Haikou 571100, China; 2Department of Obstetrics and Gynecology, Baota District People's Hospital, Yan'an City, Yan'an 716000, China
关键词:
妊娠期糖尿病;  白细胞介素-16;  基因多态性;  易感性;  妊娠结局
Keywords:
Gestational diabetes mellitus;  Interleukin-16;  Gene polymorphism;  Susceptibility;  Pregnancy outcome
DOI:
10.3760/cma.j.cn121383-20210106-01014
摘要:
目的 探讨白细胞介素(IL)-16基因多态性与妊娠期糖尿病(GDM)易感性的关联性,并分析其对妊娠结局的影响。方法 连续性选取2018年1月至2020年1月海南省妇女儿童医学中心收治的125例GDM患者作为GDM组,另依据1:1配对原则选取同期、同年龄段、同孕周的125名健康孕妇作为对照组。比较两组基线资料、IL-16基因多态性、血清IL-16水平,并比较GDM不同IL-16基因型患者空腹血糖(FPG)、稳态模型评估-胰岛素抵抗指数(HOMA-IR)、口服葡萄糖耐量试验(OGTT)结果,采用logistic回归方程分析GDM的相关影响因素,比较GDM不同基因型患者妊娠结局。结果 GDM组有糖尿病家族史占比(15.20%)高于对照组(4.00%),血清IL-16水平高于对照组(P均<0.05); GDM组IL-16基因rs11556218位点GG基因型占比(12.00%)、等位基因G占比(33.60%)均高于对照组(1.60%、21.20%),P均<0.05; IL-16基因rs11556218位点GG基因型GDM患者FPG、HOMA-IR、OGTT 0、1、2 h血糖值及血清IL-16水平高于TT、TG基因型患者(P均<0.05); 有糖尿病家族史、血清IL-16水平升高、IL-16基因rs11556218位点基因型为GG均与GDM的发生显著相关(P均<0.05); rs11556218位点GG基因型会增加GDM患者不良妊娠结局发生率。结论 IL-16基因rs11556218位点基因多态性与GDM易感性显著相关,其GG基因型可增加不良妊娠结局发生率。
Abstract:
Objective To investigate the relationship between interleukin-16(IL-16)gene polymorphism and susceptibility to gestational diabetes mellitus(GDM), and to analyze its influence on pregnancy outcome.Methods A total of 125 patients with GDM admitted to Hainan Women and Children Medical Center from January 2018 to January 2020 were continuously selected as the GDM group. In addition, 125 healthy pregnant women in the same period, the same age, and the same gestational age were selected according to the 1:1 matching principle as the control group. The baseline data, IL-16 gene polymorphism, and serum IL-16 levels were compared between the two groups. The results of fasting plasma glucose(FPG)and homeostasis model assessment-insulin resistance(HOMA-IR), and oral glucose tolerance test(OGTT)were compared in GDM patients with different IL-16 genotypes. The logistic regression equation was used to analyze the related factors of GDM, and the pregnancy outcomes of patients with different genotypes of GDM were compared.Results The proportion of family history of diabetes in the GDM group(15.20%)was higher than that in the control group(4.00%)(all P<0.05). The proportion of GG genotype(12.00%), proportion of allele G(33.60%)at the rs11556218 locus of IL-16 gene in GDM group were higher than those of control group(1.60%, 21.20%), all P<0.05. The FPG, HOMA-IR, OGTT 0, 1, 2 h blood glucose levels and serum IL-16 levels of GDM patients with GG genotype at rs11556218 locus of IL-16 gene were higher than those of TT and TG patients(all P<0.05). With a family history of diabetes, elevated serum IL-16 levels, and genotype GG at rs11556218 of the IL-16 gene all significantly increased the risk of GDM(P<0.05). The GG genotype at the rs11556218 locus increases the incidence of adverse pregnancy outcomes in patients with GDM.Conclusion The genetic polymorphism of IL-16 gene rs11556218 is significantly related to the susceptibility to GDM, and its GG genotype can significantly increase the incidence of adverse pregnancy outcomes.

参考文献/References:

[1] 娜仁其木格,李冬梅,米林香,等.中国妊娠期糖尿病患病率的Meta分析[J].中国循证医学杂志,2018,18(3):280-285.DOI:10.7507/1672-2531.201710044.
[2] 邱淑芬,姜云.妊娠期糖尿病流行病学特征及危险因素和预防措施分析[J].中国预防医学杂志,2019,20(5):451-454.DOI:10.16506/j.1009-6639.2019.05.023.
[3] 王彬苏,周秋明,盛望望,等.中国妊娠期糖尿病危险因素及妊娠结局的调查分析[J].中国医刊,2019,54(9):1014-1019.DOI:10.3969/j.issn.1008-1070.2019.09.028.
[4] Hajifaraji M,Jahanjou F,Abbasalizadeh F,et al.Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial[J].Asia Pac J Clin Nutr,2018,27(3):581-591.DOI:10.6133/apjcn.082017.03.
[5] 冯霖,朱香清,乔玉芳,等.妊娠糖尿病患者血清脂联素表达及与炎症因子、胰岛素抵抗关系[J].中国计划生育学杂志,2019,27(2):210-212,217.DOI:10.3969/j.issn.1004-8189.2019.02.018.
[6] Cheng F,Liu L,Zhang H,et al.Association of IL-16 gene polymorphisms with the risk of developing type 2 diabetes mellitus in the Chinese Han population[J].Biosci Rep,2019,39(8):BSR20190821.DOI:10.1042/BSR20190821.
[7] Farrokhi M,Masoudifar A,Derakhshan A,et al.The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of multiple sclerosis[J].Immunol Invest,2017,2(1):1-9.DOI:10.1080/08820139.2016.1268154.
[8] Karkhane M,Mohebbi SR,Azimzadeh P,et al.Genetic association between a single nucleotide polymorphism in interleukin-16(rs4072111)and susceptibility to chronic HCV infection in an Iranian population[J].Gastroenterol Hepatol Bed Bench,2018,11(1):42-47.
[9] Berger H,Gagnon R,Sermer M,等; 中国全科医学编辑部(译).2016 SOGC临床实践指南:妊娠期糖尿病[J].中国全科医学,2016,19(32):3907-3908.DOI:10.1016/j.jogc.2016.04.002.
[10] 戴琼,王晏芹,夏剑清,等.1996-2018年我国妊娠期糖尿病流行病学研究论文的文献计量分析[J].中国妇幼卫生杂志,2019,10(3):67-70.DOI:10.19757/j.cnki.issn1674-7763.2019.03.018.
[11] 韩娜,刘珏,金楚瑶,等.2013-2017年北京市通州区34 637例孕妇妊娠期糖尿病流行情况及其影响因素研究[J].中华疾病控制杂志,2019,23(2):156-161.DOI:10.16462/j.cnki.zhjbkz.2019.02.007.
[12] 米丽邦古丽·吾布里,马英,丁桂凤,等.转化生长因子-β基因多态性与新疆地区维汉妊娠期糖尿病易感性的关系分析[J].实用药物与临床,2018,21(7):761-765.DOI:10.14053/j.cnki.ppcr.201807010.
[13] 陈高琴,张燕,何广营,等.TCF7L2基因位点rs7903146 T/C单核苷酸多态性与妊娠期糖尿病孕妇遗传易感性之间的相关性[J].中国优生与遗传杂志,2019,27(3):263-265.DOI:10.13404/j.cnki.cjbhh.2019.03.003.
[14] Matalliotakis M,Zervou MI,Eliopoulos E,et al.The role of IL-16 gene polymorphisms in endometriosis[J].Int J Mol Med,2018,41(3):1469-1476.DOI:10.3892/ijmm.2018.3368.
[15] 贾慧,黄丽敏,刘颖,等.白细胞介素16基因多态性与汉族人群糖尿病的相关性[J].中国实验诊断学,2018,22(10):1778-1780.DOI:10.3969/j.issn.1007-4287.2018.10.036.
[16] Wang P,Wang H,Li C,et al.Dysregulation of microRNA-657 influences inflammatory response via targeting interleukin-37 in gestational diabetes mellitus[J].J Cell Physiol,2019,234(5):7141-7148.DOI:10.1002/jcp.27468.
[17] 田艺,杨瑾,张坤,等.妊娠期糖尿病患者胎盘中炎症反应、氧化应激对GLUT-1信号转导的影响[J].海南医学院学报,2018,24(2):206-209.DOI:10.13210/j.cnki.jhmu.20180105.007.
[18] Shih LC,Chang WS,Lee HT,et al.Interaction of interleukin-16 genotypes with betel quid chewing behavior on oral Cancer in Taiwan[J].In Vivo,2020,34(4):1759-1764.DOI:10.21873/invivo.11969.
[19] de Souza VH,de Alencar JB,Tiyo BT,et al.Association of functional IL-16 polymorphisms with cancer and cardiovascular disease:a meta-analysis[J].Oncotarget,2020,11(36):3405-3417.DOI:10.18632/oncotarget.27715.
[20] Ma X,Chen Y,Zhang Q,et al.Interleukin-16 rs11556218 is associated with a risk of osteoporosis in Chinese postmenopausal women[J].Eur J Obstet Gynecol Reprod Biol,2017,210:90-93.DOI:10.1016/j.ejogrb.2016.10.009.
[21] 贾慧,刘群,毛瑞涛.糖尿病患者血清白细胞介素16和caspase-3表达的意义[J].中国实验诊断学,2018,22(9):1562-1563.DOI:10.3969/j.issn.1007-4287.2018.09.025.
[22] 王蓉,贺婷婷,钱文嘉.糖尿病肾病患者血清同型半胱氨酸、白细胞介素-6水平与肾脏功能及预后的关系[J].检验医学与临床,2019,16(13):1883-1885.DOI:10.3969/j.issn.1672-9455.2019.13.026.

相似文献/References:

[1]詹永颖,黄汉伟.益生菌对妊娠期糖尿病的影响及相关机制[J].国际内分泌代谢杂志,2021,41(02):124.[doi:10.3760/cma.j.cn121383-20200821-08037]
　Zhan Yongying,Huang Hanwei..Effects and mechanism of probiotics on gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2021,41(02):124.[doi:10.3760/cma.j.cn121383-20200821-08037]
[2]郭敏珊,陈小燕,梁伟,等.妊娠期糖尿病患者启动药物干预风险模型的建立[J].国际内分泌代谢杂志,2022,42(05):349.[doi:10.3760/cma.j.cn121383-20210712-07031]
　Guo Minshan,Chen Xiaoyan,Liang Wei,et al.Construction of a risk model for initiating pharmacological intervention in gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2022,42(02):349.[doi:10.3760/cma.j.cn121383-20210712-07031]

备注/Memo

备注/Memo:
通信作者:卓然然,Email:d199vg@163.com
更新日期/Last Update: 2022-04-20